Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension.
作者信息
Webb David J
机构信息
Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, UK.
出版信息
Cardiovasc Res. 2024 Sep 2;120(10):e41-e43. doi: 10.1093/cvr/cvae140.
PMID:39222421
Abstract
摘要
Zotero 插件